Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
contract research organization
CRO
Private equity firm acquires CRO CenExel
Boston-based BayPine has acquired a majority stake in the company, leaving former majority owner Webster Equity Partners with a minority stake.
Darren Incorvaia
Apr 15, 2025 12:50pm
Canadian CRO Innovaderm rebrands to Indero
Mar 11, 2025 5:45am
CRO Lindus closes fruitful $55M series B
Jan 22, 2025 11:44am
Clinical trials to grapple with new tech, uncertainty in '25
Dec 26, 2024 9:00am
Charles River expands biotech incubator to discovery stage
Dec 6, 2024 2:55pm
AmplifyBio shutters Bay Area site, lays off Ohio CRO staff
Dec 6, 2024 11:31am
